Jayen Patel, MD
Pain Medicine · Tulsa, OKNPI 1215028204
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,628 of the $10,278 with a category attached, or 83.9%. 32 manufacturers reported payments, led by Medtronic at 27.3% of the total. Reporting peaked in 2020 at $2,164 and has fallen 50.9% since, to $1,062 in 2025.
Across 219 payments — averaging $46.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$2K
- VGI Medical, LLC$2K
- Nalu Medical, Inc.$1K
- Abbott$334
- Saluda Medical Americas, Inc.$253
- plus $2K from 26 others
What the payments were for
- Travel & lodging$2172%
- Food & beverage$8,62884%
- Entertainment$1,43314%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 64 | $2,802 |
| Boston Scientific | 51 | $2,100 |
| VGI Medical, LLC | 4 | $1,904 |
| Nalu Medical, Inc. | 20 | $1,067 |
| Abbott | 8 | $334 |
| Saluda Medical Americas, Inc. | 2 | $253 |
| AbbVie(2 entities) | 14 | $240 |
| Pfizer | 11 | $187 |
| Nevro Corp. | 2 | $158 |
| Collegium Pharmaceutical, Inc. | 9 | $157 |
| Lundbeck LLC | 2 | $131 |
| Avanos Medical | 2 | $130 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $125 |
| Stimwave Technologies Incorporated | 1 | $107 |
| Amgen | 4 | $80 |
| Biodelivery Sciences International, Inc. | 3 | $63 |
| Si-bone, Inc. | 1 | $52 |
| Biotronik Inc. | 1 | $50 |
| Pacira Pharmaceuticals Incorporated | 2 | $46 |
| Vertiflex, Inc. | 2 | $45 |
| Convatec Inc. | 2 | $42 |
| Organogenesis Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Forte Bio-pharma LLC | 1 | $23 |
| Tersera Therapeutics LLC | 1 | $21 |
| Bioventus LLC | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Appliedvr Inc | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SiJoin$1,536
- INTELLIS ADAPTIVESTIM$930
- Nalu Neurostimulation System$707
- Superion Indirect Decompression System$385
- TARGETSTIM$293
- SiJoin/VerteLoc/VerteLP$262
- INTELLIS$248
- VANTA ADAPTIVESTIM$200
- Evoke$191
- PROCLAIM$177
- Infinion 16$130
- Senza Spinal Cord Stimulation System$124
- WaveWriter Alpha Prime 16$110
- VYEPTI$109
- StimQ Receiver Stimulator Kit Channel A US w Receiver$107
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$107
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$107
- Freedom 4A Receiver Kit Channel A US w Receiver$107
- Freedom 8A Receiver Kit Channel A US w Receiver$107
- SiJoin, VerteLoc$106
How this compares
$10,278 in reported general payments places this provider in the 75th percentile of 68 pain medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 35 | $46,032 |
| Nurtec OdtRimegepant Sulfate | 19 | $40,598 |
| Xtampza ErOxycodone Myristate | 88 | $33,189 |
| BelbucaBuprenorphine Hcl | 38 | $31,095 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 745 | $20,893 |
| Hysingla ErHydrocodone Bitartrate | 36 | $16,456 |
| OxycontinOxycodone Hcl | 36 | $14,338 |
| Buprenorphine | 61 | $12,599 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 392 | $12,556 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 38 | $5,838 |
| Morphine Sulfate ErMorphine Sulfate | 209 | $5,239 |
| Buprenorphine Hcl | 108 | $4,531 |
| Gabapentin | 246 | $3,133 |
| Oxycodone Hcl | 225 | $3,074 |
| Lidocaine | 19 | $2,903 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $157 | $64,283126 claims |
| AbbVieBotox | $240 | $46,03235 claims |
| PfizerNurtec Odt | $187 | $40,59819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 68 pain medicine providers in Oklahoma.
Other pain medicine in Tulsa
- Brian TorgersonTulsa$13K
- Lam NguyenTulsa$11K
- Hugo SalgueroTulsa$10K
- Adam WallaceTulsa$8K
- Kenneth ReedTulsa$7K
- Ahmad KhattabTulsa$7K
- David DoTulsa$6K
- Emad Attallah-WasifTulsa$4K
- Leslie ChanTulsa$4K
- Chancen HallTulsa$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.